Owlet (OWLT) Other Accumulated Expenses (2020 - 2021)

Owlet's (OWLT) quarterly Other Accumulated Expenses came in at $3.9 million in Q3 2021, up 173.79% on a QoQ basis from $1.4 million in Q4 2020.

Owlet (OWLT) Other Accumulated Expenses (2020 - 2021) Analysis & Trends

Owlet (OWLT) has 2 years of Other Accumulated Expenses data on file, last reported at $3.9 million in Q3 2021.

On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $3.9 million in Q3 2021; TTM through Sep 2021 was $3.9 million, a N/A change from a year earlier, with the FY2020 full-year figure at $1.4 million, changed N/A from the prior year.
Other Accumulated Expenses for Q3 2021 stood at $3.9 million, up from $1.4 million in the prior quarter.
Over the last five years, Other Accumulated Expenses for OWLT reached as high as $3.9 million in Q3 2021 and fell as low as $1.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Owlet	147.80 Mn	106.79 Mn	12.24 Mn

Download Data

Date	Value
Sep 30, 2021	3.90 Mn
Dec 31, 2020	1.42 Mn